Results 1 to 10 of about 772 (167)

Safety and Efficacy of Lotilaner Ophthalmic Solution (0.25%) in Treating Demodex Blepharitis: Pooled Analysis of Two Pivotal Trials [PDF]

open access: yesOphthalmology and Therapy
Introduction Lotilaner ophthalmic solution (0.25%) is the first United States Food and Drug Administration (US FDA)-approved drug for treating Demodex blepharitis.
Marc R Bloomenstein   +2 more
exaly   +4 more sources

High Prevalence of Lash Collarettes in Patients with Atopic Dermatitis Treated with Dupilumab [PDF]

open access: yesActa Dermato-Venereologica
Ilaria Trave   +11 more
doaj   +7 more sources

Demodex folliculorum  [PDF]

open access: yesDiagnostics
Herein, we present scanning electron microscopy imagery of Demodex folliculorum on the eyelashes of a patient with a two-year history of dry, burning, and watery eyes.
Ayyad Zartasht Khan   +6 more
doaj   +3 more sources

Use of saline‐soaked bacterial culture swabs increases bacterial recovery in dogs with superficial bacterial folliculitis [PDF]

open access: yesVeterinary Dermatology
Background – Canine superficial bacterial folliculitis (SBF) is a common recurrent condition with a growing requirement for culture and susceptibility as a consequence of increased antimicrobial resistance and antimicrobial stewardship. Different opinions persist about the ideal technique for culture sample acquisition, which varies with lesion ...
Jason B Pieper   +2 more
exaly   +3 more sources

Unveiling Species Diversity Within Early-Diverging Fungi from China VIII: Four New Species in Mortierellaceae (Mortierellomycota) [PDF]

open access: yesMicroorganisms
The fungal family Mortierellaceae represents ubiquitous and ecologically significant components of soil ecosystems across terrestrial habitats. Through an integrative taxonomic approach combining multi-locus phylogenetic analyses (ITS, LSU, SSU rDNA ...
Xin-Yu Ji   +5 more
doaj   +3 more sources

Lotilaner ophthalmic solution 0.25% in the treatment of blepharitis: A case report [PDF]

open access: yesSAGE Open Medical Case Reports
Demodex blepharitis is a chronic inflammatory ocular condition caused by Demodex mite infestation of the eyelid that can negatively impact quality of life.
Paul Karpecki   +14 more
doaj   +2 more sources

Association between lid margin collarettes and dry eye disease severity in the Dry Eye Assessment and Management (DREAM) study [PDF]

open access: yesEye
Abstract Background/objectives Lid margin collarettes are a distinct clinical finding and their association with meibomian gland dysfunction (MGD) and dry eye symptoms and signs remains uncertain.
Eliot N Haddad   +2 more
exaly   +5 more sources

blepharitis treatment with a selenium sulfide-containing ointment: a case report [PDF]

open access: yesTherapeutic Advances in Ophthalmology
Demodex blepharitis is a chronic, progressive condition characterized by inflammation, ocular irritation, and erythema due to an overgrowth of mites in hair follicles and oil glands of the eyelids.
Yair Alster   +2 more
doaj   +2 more sources

Dermoscopic Features of Eccrine Poromas in Diverse Skin Phototypes: A Retrospective Study of 26 Cases [PDF]

open access: yesDermatology Practical & Conceptual
Introduction: Eccrine poroma (EP) is a benign adnexal tumor. Establishing a definitive diagnosis based on clinical and dermoscopic findings can be challenging. Objectives: The aim of this study is to perform a comprehensive analysis of the dermoscopic
Bengu Nisa Akay   +2 more
doaj   +2 more sources

Synopsis of the antimicrobial use guidelines for canine pyoderma by the International Society for Companion Animal Infectious Diseases (ISCAID). [PDF]

open access: yesVet Dermatol
Abstract Background Canine pyoderma is one of the most common presentations in small animal practice, frequently leading to antimicrobial prescribing. Objectives To provide clinicians with antimicrobial treatment guidelines for staphylococcal pyoderma, including those involving meticillin‐resistant staphylococci.
Loeffler A   +9 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy